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Introduction
Phosphorylation is involved in many cellular events, often serving as a molecular switch to regulate signalling pathways. The fission yeast genome contains 96 protein kinases (www.pombase.org [1] ). A variety of genetic materials and methods have been developed to investigate the function of each kinase in Schizosaccharomyces & 2014 The Authors. Published by the Royal Society under the terms of the Creative Commons Attribution License http://creativecommons.org/licenses/by/3.0/, which permits unrestricted use, provided the original author and source are credited.
pombe. For kinases that are indispensable for cell growth, it is common to use conditional mutants to knockdown the gene function. Those include temperature-sensitive (ts) mutants, which lose functions at the restrictive temperature. Although this method provides a powerful genetic tool, it poses practical problems for cell biology. For instance, it is difficult to reduce kinase activity rapidly during live-cell imaging because of the technical difficulties involved in changing the temperature. Furthermore, most mutants are not well characterized with regard to how fast the activity is lost following shift to the restrictive temperature. Small molecules are frequently used as kinase inhibitors, particularly for the analysis of cultured mammalian cells; however, many of these work poorly on yeast cells (for example, fig. 1 of [2] ).
These technical difficulties were solved by a so-called chemical genetics approach [3] . Substitution of a single amino acid in the adenosine triphosphate (ATP)-binding pocket of a kinase (the so-called gatekeeper residue) renders the mutant kinase sensitive to ATP-analogue molecules that cannot fit into the active site of an unmodified kinase. This confers specificity to the inhibitor, as genetically unmodified kinases are unaffected by ATP-analogues. They also inhibit the kinase function rapidly (approximately minutes after a drug addition to the medium [4] ), permitting time-lapse observation over short time scales. In principle, the gatekeeper residue of any kinase can be predicted from its amino acid sequence [5, 6] , which has prompted the construction of an as-mutant collection of fission yeast essential kinases [7] . Analogue-sensitive mutants are now widely used for analyses of cell cycle regulation.
Mitotic progression is controlled by protein kinases that have been conserved from yeast to human [8] . The main mitotic kinases include cyclin-dependent kinase 1 (Cdk1), known as Cdc2 in fission yeast and Cdc28 in budding yeast [9] [10] [11] ; the polo kinase, known as Plo1 in fission yeast and Cdc5 in budding yeast [12] [13] [14] ; and the single aurora kinase (equivalent to aurora B), which is known as Ark1 in fission yeast and Ipl1 in budding yeast [15, 16] . Analoguesensitive mutants of these mitotic kinases have been described: fission yeast cdc2-as [17] and budding yeast cdc28-as1 [3] for Cdk1; cdc5-as [18] and plo1-as [7] for polo kinase; and ark1-as2/as3 [19] and ipl1-as [5] for aurora B kinase.
Cdc2/Cdc28 regulates both the G1/S and G2/M transitions in S. pombe and Saccharomyces cerevisiae. Comprehensive proteomics analyses using cdc28-as1 in budding yeast have identified more than 300 Cdk1 substrates [4, 20] . In S. pombe, Cdc2 is required both for the G1/S and G2/M transitions (for review, see [21] ). Many mitotic substrates have been identified; for example, Cdc2 is required for activation of Plo1 [22] , for faithful chromosome segregation through controlling localization of the chromosomal passenger complex (CPC) [23] and Nsk1 [24] , for chromosome condensation through nuclear accumulation of the condensin Cut3/SMC4 [25, 26] , and for localization of the microtubule-associated protein (MAP) Dis1/tumour overexpressed gene (TOG) at kinetochores [27, 28] . Cdc2 is also required for activation of the anaphase-promoting complex (APC/cyclosome) [29] [30] [31] .
Combining analogue-sensitive mutants of mitotic kinases with microscopy of living cells provides a way to investigate kinase function during short periods of the cell cycle (e.g. metaphase or anaphase): addition of the inhibitory analogue decreases the activity of the kinase rapidly, to the extent desired [17, 32] . This approach has revealed that Cdc2 is required for the nuclear accumulation of the MAP complex Alp7/transforming acidic coiled-coil-Alp14/TOG in early stages of mitosis, which facilitates bipolar spindle assembly [33] [34] [35] , and in late mitosis, downregulation of Cdc2 promotes the asymmetric localization of septum initiation network proteins at spindle pole bodies (SPBs, the centrosome equivalent in yeast) [17, 36] .
Although analogue-sensitive mutants can be easily made by substitution of the gatekeeper amino acid, this mutation occasionally has deleterious effects. The fission yeast cdc2-as mutant is generated by the F84G mutation. However, in addition to analogue sensitivity, the cells are elongated at 258C, indicating a delay in mitotic commitment, and they are also heat-sensitive, particularly at 368C, even in the absence of the ATP-analogue molecule [17] . In addition, the cdc2-as mutant is defective in sexual differentiation (mating and meiosis) and the mutant zygotes produce two-spore asci instead of four-spore ones of the wild-type zygotes [17] . Such phenotypes have been observed in other hypomorphic alleles of Cdc2 [37] [38] [39] and the meiotic mutant cdc2-N22/tws1 [40, 41] , indicating that the gatekeeper mutation reduces Cdc2-Cdc13 activity per se. This limits the usefulness of the cdc2-as allele in certain circumstances. For example, it is difficult to combine cdc2-as with many heat-sensitive mutants that require incubation at 368C to arrest efficiently (e.g. cdc25-22 [42] ); cdc2-as also shows a negative interaction with mutants that arrest in mitosis, such as the b-tubulin mutants nda3-311 (cs) and nda3/alp12-1828 (ts) [43] [44] [45] . This incompatibility of the cdc2-as mutation with key mutants used to impose cell cycle arrests limits its utility for the analysis of some mitotic functions of Cdc2-Cdc13.
Meiosis in fission yeast consists of pre-meiotic DNA replication, meiotic recombination during meiotic prophase, and two consecutive rounds of chromosome segregation (meiosis I and meiosis II) without an intervening S phase, prior to sporulation. To achieve this meiosis-specific cell cycle progression, the Cdc2 activity is regulated in a special manner during meiosis. A fraction of Cdc13/cyclin B is protected from degradation even after anaphase onset of meiosis I to provide CDK activity for the onset of meiosis II [46] ; this contrasts with the situation in mitosis, where Cdc13 is entirely degraded at anaphase onset. Degradation of Cdc13 by the APC/cyclosome is inhibited by Mes1 after anaphase onset of meiosis I [46] , whereas CDK must be fully inactivated after meiosis II to avoid 'meiosis III' [47] . The unique modulation of Cdc2-Cdc13 implies that the function of Cdc2 in meiosis may differ from that in mitosis. The multiple roles of Cdc2 in meiosis have limited the use of conditional mutants to analyse its function. The existing cdc2-as mutant is also limited in its suitability for studies in meiosis, owing to production of dyads, in contrast to tetrads that wild-type zygotes produce [17] .
Thus, although the previously described cdc2-as mutant is a powerful tool, it also has technical limitations in some experimental settings. We therefore decided to use natural selection to modify the cdc2-as allele to eliminate the undesirable hypomorphic phenotypes by additional mutations. We have used this improved cdc2-as allele to examine various functions of cdc2 during mitosis and meiosis.
Results and discussion

Isolation of intragenic suppressor mutants of cdc2-as
The original cdc2-as mutant gene contains a single amino acid substitution (F84G) at the gatekeeper residue [17] rsob.royalsocietypublishing.org Open Biol. 4: 140063 (figure 1a). We performed an error-prone PCR to introduce additional mutations to the cdc2-as gene containing the open reading frame and 500 bp upstream and downstream flanking regions (the strategy is summarized in the electronic supplementary material, figure S1a). The amplified 2.2 kb fragment was used for transformation of the original cdc2-as mutant, selecting for colony formation at 368C (electronic supplementary material, figure S1a,b). We expected that these survivors should include intragenic suppressor mutations. We chose 17 colonies that survived at 368C, and restreaked onto the YE5S plate (rich medium) containing phloxine B, which stains dead cells. Eight of 17 colonies (named M1, M2, M6, M8, M10, M11, M12 and M17) grew well at 368C as well as at 208C (electronic supplementary material, figure S1b), therefore those candidates were neither ts nor cs. Importantly, all of these survivors remained sensitive to the ATP-analogue molecule 1NM-PP1 (electronic supplementary material, figure S1b), indicating that none of the survivors were revertants of the as mutation.
Based upon these assays, we retained the M17 mutant, in which ts and cs phenotypes were significantly suppressed, for further analyses (the mutant allele is called cdc2-asM17 hereafter; figure 1a ). We next inserted the bsd gene (conferring the blasticidin S resistance [48] ) as the selection marker for the modified cdc2-asM17 gene. The bsd gene was inserted at the approximately 0.5 kb downstream of the termination codon of the cdc2-asM17 gene (the allele is called cdc2-asM17 þ bsd hereafter; figure 1a), and this did not affect the function of Cdc2 (electronic supplementary material, figure S1b,c).
To validate cdc2-asM17 and cdc2-asM17 þ bsd mutants as new tools for general purposes, we evaluated whether they behave normally in the absence of ATP-analogues, because the original cdc2-as mutant is slightly deficient in cell cycle [17] . First, we measured the cell size of cdc2-asM17 (+bsd) mutants rsob.royalsocietypublishing.org Open Biol. 4: 140063 at cell division. As shown in figure 1b, cdc2-as cells were slightly longer than wild-type (WT) cells [17] , indicating compromised CDK activity. The elongation was not observed in the cdc2-asM17 and cdc2-asM17 þ bsd strains. This was confirmed by a growth curve assay of four strains (WT, cdc2-as, -asM17, -asM17 þ bsd; figure 1c ): the growth of the cdc2-as strain was slightly slower than WT, whereas the cdc2-asM17 and -asM17 þ bsd strains grew at the same rate as WT. Next, we performed FACS analysis to examine the DNA content of cdc2-asM17 mutants. As shown in figure 1d , cdc2-asM17 and -asM17 þ bsd mutants displayed similar DNA content profiles compared with WT, indicating that cell cycle progression of those mutants is similar to WT in the absence of the inhibitory drug. Because the DNA structure check point depends upon Cdc2 for activity, we examined whether cdc2-asM17 mutants were sensitive to genotoxins. Although the original cdc2-as strain was slightly sensitive to hydroxyurea (HU), UV and camptothecin (CPT), the cdc2-asM17 strains were not ( figure  1e ). Finally, we investigated whether cdc2-asM17 remains associated with Suc1 (p13suc1), which is known to interact with the Cdc2-cyclin B complex [49] . A pulldown assay using p13 Suc1-beads indicated that the cdc2-asM17 mutation did not affect interaction between CDK and Suc1, in the absence of ATP-analogues (electronic supplementary material, figure S2 ). Together the data described above, we demonstrate that the cdc2-asM17 mutant (+bsd) behaves similarly to WT in assays where the original cdc2-as allele shows clear defects, thereby validating its use to study the role of Cdc2 activity during mitotic cell cycle in several conditions where the original cdc2-as was not functional. Insertion of the bsd marker gene at the downstream of the cdc2 gene did not cause abnormality as far as we have tested (figure 1b-e).
Next, we investigated if the cdc2-asM17 mutant suppressed the meiotic defects seen in the original cdc2-as mutant. Homothallic h 90 cdc2-asM17 cells underwent mating and meiosis, and mostly generated four nuclei and four spores per cell, as in WT, whereas the original cdc2-as cells generated abnormal two or three nuclei and two or three spores [17] (figure 2a-c). cdc2-asM17 þ bsd also generated four nuclei and four spores per cell (figure 2a-c). Spore viabilities of cdc2-asM17 (91%, n ¼ 108) and cdc2-asM17 þ bsd (94%, n ¼ 108) are comparable with that of WT (100%, n ¼ 104), indicating that cdc2-asM17 and cdc2-asM17 þ bsd mutants undergo meiosis and produce viable spores to a similar extent to WT. Thus, these mutants are suitable for analysis of Cdc2 functions in meiosis, which could not be addressed using the original cdc2-as mutant. Sporulation of five other suppressor mutants (M1-M11) was also examined, and sporulation defects of the original cdc2-as mutant were in general suppressed to some extent (electronic supplementary material, figure S3 ).
Characterization of the suppressor mutations
We then sequenced the cdc2 gene of the suppressor mutants. Interestingly, mutants M11 and M17 possessed mutations at the same residue, lysine 79 (figure 3a). M11 had a substitution of K79 to T (threonine), whereas M17 had a substitution of K79 to E (glutamic acid). The mutation site was close to the as mutation site F84G in the primary structure. M10 had a substitution of glutamine at five to glutamic acid (Q5E). To explore how the suppressor mutation in the mutant M17 (K79E) suppressed the as mutation (F84G), the secondary and tertiary structure of the mutant protein was subjected to the protein folding prediction program PHYRE2 (http://www.sbg.bio.ic.ac.uk/phyre2/) [50] . For the sake of simplicity, we used amino acid residues 1-149 (from the N-terminus to the b7 sheet), which form the N-terminal lobe of the kinase [51] . Introduction of the analogue-sensitive mutation F84G was predicted to generate a structural alteration around the ATP binding pocket (Cdc2-as; figure 3b ). The deformation of the ATP binding pocket was suppressed by the additional introduction of K79E (Cdc2-asM17; figure 3b ). Consistent with this result, mutations within a b sheet in the N-terminal lobe have been reported to suppress the gatekeeper mutations that are not tolerated in several kinases [52] . It is possible that the introduction of K79E, which locates at the edge of the b sheet, may twist the sheet, so that the opposite edge of the sheet harbouring F84G alters the angle at the ATP-binding pocket. Kinase assays of WT Cdc2 and Cdc2-asM17 revealed that the activity of asM17, but not of WT rsob.royalsocietypublishing.org Open Biol. 4: 140063
Cdc2, was inhibited by addition of 10 2 -10 3 nM of the ATPanalogue 1NM-PP1 (figure 3c). Although the suppressor mutation rescues all the phenotypic defects of cdc2-as, the in vitro kinase assay nonetheless reveals that Cdc2-asM17 is less active than WT Cdc2 in the absence of 1NM-PP1 (figure 3c).
3.3. Cdc2 and the SAC: the use of cdc2-asM17 with MBC or the b-tubulin ts mutant
Elevation of the Cdc2 kinase activity induces assembly of the bipolar spindle at mitotic onset. If microtubule formation is perturbed by internal mutations or drugs, then the attachment of kinetochores to microtubules may be inhibited. The spindle assembly checkpoint (SAC) monitors kinetochore-microtubule attachment to ensure faithful chromosome segregation in mitosis. The SAC components Mad1-Mad2 recognize unattached kinetochores and arrest cell cycle progression at metaphase until correct attachment has been accomplished. Recent studies in yeast, flies, frogs and humans have suggested that Cdk1 can serve as an upstream activator of the SAC [53] [54] [55] [56] [57] [58] . We therefore used the cdc2-asM17 mutant to examine whether CDK activity is required to maintain an SAC arrest in S. pombe. First, we tested whether the microtubule drug methyl benzimidazol-2-yl-carbamate (MBC) induces cdc2-as cells to rsob.royalsocietypublishing.org Open Biol. 4: 140063 arrest at metaphase; the original cdc2-as mutant was sensitive to a low concentration of MBC (10 mg ml 21 ), which did not prevent colony formation in WT cells (figure 4a). By contrast, the cdc2-asM17 mutant was not sensitive to MBC (figure 4a). We therefore constructed the cdc2-asM17 strain expressing Mad2-GFP, the kinetochore marker Mis6-2mRFP and the SPB marker Sid4-2ECFP. Cells were treated with MBC to induce metaphase arrest; bright Mad2-GFP signal was observed at kinetochores, which is a hallmark of SAC activation (21 min, figure 4b ). Cells were then filmed and 1NM-PP1 or DMSO was added to the medium (0 min, figure 4b ). In the DMSO treatment, Mad2-GFP dots remained at kinetochores for longer than 15 min (þDMSO, figure 4b,d ).
By contrast, Mad2-GFP dots mostly disappeared within 4 min after 1NM-PP1 addition (þ1NM-PP1, figure 4b,d ). This demonstrates that Cdc2 kinase activity is required for maintenance of SAC activation in the presence of microtubule perturbation, through Mad2 recruitment to kinetochores. A very recent study in human cells has shown that Mad2 recruitment to kinetochore requires Cdk1 activity [59] , suggesting that this mechanism has been conserved through evolution. We examined this further using the ts b-tubulin mutant nda3/alp12-1828, which was impossible to combine with the original cdc2-as mutant, because the long G2-phase of S. pombe results in a predominant G2-arrest owing to temperature sensitivity of the cdc2-as allele. After shift to 368C, the nda3-1828 cdc2-asM17 mutant efficiently arrested at prometaphase without a spindle, and Mad2-GFP dots were associated with kinetochores (21 min, figure 4c ). In the presence of 1NM-PP1, Mad2-GFP dots mostly disappeared within 4 min (þ1NM-PP1, figure 4c,d) , confirming that SAC maintenance requires Cdc2 activity during mitosis. These experiments also demonstrate the utility of the analoguesensitive mutant cdc2-asM17 to investigate the involvement of Cdc2 in mitotic events such as the SAC. Recently, it was reported that SAC silencing (inactivation) during mitosis is achieved by the protein phosphatase PP1 [60 -63] . The fission yeast has two PP1 phosphatases, Dis2 and Sds21 [64, 65] , though only Dis2 has a function in SAC silencing [61] . To test whether Dis2/PP1 is required for the SAC silencing following Cdc2 inactivation (as shown in figure 4 ), we created the double mutant cdc2-asM17 nda3-KM311. The double mutant of the original cdc2-as and nda3-KM311 did not enter mitosis efficiently, owing to the cold-sensitivity of cdc2-as [17] . By contrast, the cdc2-asM17 nda3-KM311 cells arrested efficiently in mitosis at 188C with a strong nuclear signal of cyclin B/ Cdc13-YFP, (0 min, figure 5a,c). When 1NM-PP1 was added to the medium, the frequency of cells harbouring Cdc13-YFP signal decreased (60 min, figure 5a,c). In contrast, when the dis2 þ gene was disrupted, the triple mutant dis2D nda3-KM311 cdc2-asM17 retained a Cdc13-YFP signal even after addition of 1NM-PP1 ( figure 5b,c) . This indicates that Cdc2 and Dis2/PP1 are required to maintain and silence the checkpoint machinery, respectively. Ark1/ aurora B kinase, a component of the CPC, is also required for SAC maintenance [61] . As centromere targeting of CPC depends on Cdk1 [23] , maintenance of the SAC by Cdc2 might be achieved through the control of CPC localization to centromeres. Alternatively, Cdc2 might regulate the SAC independently of CPC localization, because centromeric retention of CPC in anaphase does not result in APC/C inhibition (SAC activation) in human cells [66] . How Dis2 /PP1 counteracts Cdc2 in SAC silencing is an important question and will be addressed in future studies. The dis2D nda3-KM311 cdc2-asM17 mutant frequently resulted in unequal chromosome segregation with persistent nuclear Cdc13-YFP (figure 5b), indicating that checkpoint adaptation (slippage into anaphase) may occur even without complete cyclin destruction, when the Cdc2 activity is inhibited.
Shugoshin and Cdc2: the use of cdc2-asM17 in meiosis
Genetic perturbation of Cdc2 prevents entry into meiosis I [67] , making it difficult to examine the function of Cdc2 in spindle organization and chromosome segregation during meiosis I. Because the cdc2-asM17 strain does not show meiotic defects in the absence of ATP-analogues we used it to address this question.
We have previously used cdc2-asM17 strain to show that reorganization of SPBs at the onset of meiosis I requires Cdc2 activity [68] . We have now used it to examine the role of Cdc2 activity at the metaphase -anaphase transition in meiosis I. To ensure faithful segregation of chromosomes during meiosis I, proteins such as aurora B and protein phosphatase 2A (PP2A) are localized transiently to centromeres, until the onset of anaphase I [69, 70] . It is unclear whether delocalization of aurora B and PP2A at the onset of anaphase I depends on reduction of the Cdc2 activity or proteasome-dependent protein degradation.
To distinguish these two possibilities, we used slp1-s.o. cut23-s.o. mutations, in which meiotic expression of the APC/ C component Cut23 and its activator Slp1 is repressed [71] , thereby preventing proteasome-dependent protein degradation. Then, 1NM-PP1 was added to inhibit Cdc2 activity of cdc2-asM17 cells. First, we examined localization of Ark1 (aurora B). Cdc2 phosphorylates the CPC component Bir1/ survivin to recruit Ark1 to centromeres in fission yeast mitosis [23] , but it has not been tested whether this mechanism is conserved during meiosis. Ark1 localized to centromeres in cells arrested in metaphase I, and delocalized from centromeres when Cdc2 activity was reduced by addition of 1NM-PP1 ( figure 6a ). This indicates that delocalization of Ark1 from centromeres depends on reduction of the Cdc2 activity, but not on degradation of CPC components. Second, we examined the localization of Shugoshin (Sgo1), which forms a complex with PP2A and is essential for its localization at centromeres [70] . Consistent with previous studies [69] , Sgo1 localized to centromeres Figure 5 . Dis2/PP1 is required for checkpoint inactivation triggered by Cdc2 inhibition. (a) The cdc2-asM17 mutation was combined with the cs b-tubulin mutation nda3-KM311. The mutant was arrested at metaphase at 188C with high concentration of cyclin B1/Cdc13-YFP in the nucleus and at SPBs (0 min). Then, 1NM-PP1 was added to the culture. After 60 min, the percentage of cells with Cdc13-YFP decreased. Sid4-2ECFP (SPB) and DAPI are also shown. (b) Similar experiments were done with the triple mutant dis2D nda3-KM311 cdc2-asM17. Cells were cultured at 188C (0 min) and then 1NM-PP1 was added. In contrast to dis2 þ cells (a), Cdc13-YFP remained in the nucleus. Scale bars, 5 mm. (c) Frequencies of cells with nuclear Cdc13-YFP signal in dis2 þ (WT) and dis2D strains in the nda3-KM311 cdc2-asM17 background were plotted in response to 1NM-PP1 (or DMSO for negative control) addition (n 100). rsob.royalsocietypublishing.org Open Biol. 4: 140063 in metaphase I-arrested cells. Interestingly, Sgo1 did not alter its localization at centromeres even when Cdc2 activity was decreased by 1NM-PP1 (figure 6b). Thus, maintenance of the Sgo1 localization at centromeres does not require Cdc2 activity, raising the possibility that APC-mediated Sgo1 degradation might be a trigger of Sgo1 delocalization from centromeres.
Conclusion
The generation of an analogue-sensitive mutant is a powerful tool that enables chemical inhibition of any kinase of interest. In general, analogue sensitivity is conferred by introducing a single amino acid substitution of the 'gatekeeper' residue in the active site. This sometimes causes a partial loss of kinase function, as in the case of the cdc2-as mutant [17] . The original cdc2-as mutant (F84G) showed defects in growth at high and low temperature and in meiosis. We have used natural selection to suppress these defects, which occurred through an additional mutation at K79E, to generate the cdc2-asM17 mutant.
A systematic generation of analogue-sensitive mutants of all essential kinases in fission yeast found that three (of 16) essential kinases could not be generated (Cdc7, Hsk1 and Sid1), because an introduction of the analogue-sensitive mutation caused a significant loss of function [7] . For instance, it was impossible to create the sid1-as mutant, because replacement of the wild-type sid1 þ with the sid1-as mutant gene caused lethality (Y.A., S.A.K., V.S., M.Y. & M.S. 2011, unpublished data). Those issues, however, might be solved by applying the method described in this study. Specifically, if the gatekeeper mutation resides at the end of a b sheet, then the suppressor mutation could be introduced at the opposite end of the sheet (figure 3a,b) . Alternatively, it might be more judicious to allow in vivo selection to generate the required mutant, as we have done here (electronic supplementary material, figure S1a). The library of mutagenized DNA fragments could be used for transformation of the existing ts (or other) mutant of the kinase. Transformants viable at the restrictive temperature should contain the suppressor mutation in addition to the gatekeeper mutation.
The in vivo selected cdc2-asM17 mutant permitted us to undertake experiments that were not possible previously, such The strains used in this study are listed in table 1. We used standard methods for fission yeast genetics, as described previously [72] . Tagging of a single copy of a fluorescent protein (GFP) at the C-terminus of genes, and insertion of the bsd marker gene, was performed using standard PCR-based methods [73, 74] . Tagging of multiple tandem copies of fluorescent proteins (2mRFP and 2ECFP) at the C-terminus of genes was performed as previously described [34] . All the fluorescent protein-fused genes are expressed by the native promoter and the adh terminator [73] , except for cdc13-YFP, mCherry-atb2 and CFP-atb2 fusion genes. The cdc13-YFP fusion gene is expressed by the cdc13 þ promoter and terminator. The mCherry-atb2 gene is expressed by the Padh15 promoter and the adh terminator, and the CFP-atb2 gene is expressed by the Padh13 promoter and the adh terminator [75] . 1NM-PP1 (Calbiochem, CA) was added to media at the concentration of 2 mM. For figure 1b, living cells were stained with Calcofluor (Sigma, MO), and the cell length was measured on the IMAGEJ software (NIH). For the FACS analysis in figure 1d , the DNA content was measured using BD FACSCalibur (BD, NJ). For figure 2a-c, homothallic h 90 cells were induced to mating, meiosis and sporulation on sporulation agar plates. After incubation for 24 h at 308C, cells were fixed with methanol and stained with 4 0 ,6-diamidino-2-phenylindole (DAPI; Wako Pure Chemicals, Japan), and the number of nuclei and spores in each ascus were counted. For the spore viability assay, spores were dissected by the micromanipulator (Singer Instruments, Somerset, UK), and the percentage of spores that formed colonies was calculated. The checkpoint silencing assay in figure 5 was performed as previously described [61] . The prometaphasearrested nda3-KM311 cells at 188C were treated with 1 mM 1NM-PP1 or DMSO. Cells were collected at the indicated time point, fixed with methanol and stained with DAPI (Wako Pure Chemicals).
Creation of the cdc2-asM17 mutant
The creation of the original cdc2-as mutant has been described previously [17] . A flow chart for the method to generate the cdc2-asM17 mutant is depicted in the electronic supplementary material, figure S1a. Briefly, the genomic cdc2-as mutant gene was amplified from the original mutant [17] . The coding region of cdc2-as with flanking 0.5 kb up/downstream regions at both ends (in total 2.2 kb; electronic supplementary material, figure S1a) was amplified by a standard PCR method with PrimeSTAR HS DNA polymerase (Takara-Bio, Japan). The amplified fragment was gel-purified, and used as the template for the following error-prone PCR.
To induce errors, thermal cycling was performed for 40 cycles using the Ex Taq polymerase (Takara-Bio) and the same pair of oligomers used for the first PCR. The amplified fragments were then used for transformation of the cdc2-as sfi1-CFP-nat strain MJ1254 (Sfi1-CFP is an SPB marker). Colonies that grew at 368C were restreaked onto YE5S plates containing Phloxin B, to visualize suppression of temperature sensitivity. Cold sensitivity was also tested at 208C. Confirmation of the analogue sensitivity was done with YE5S plates containing 10 mM 1NM-PP1. The bsd marker gene was inserted 528 bp downstream of the termination codon of the cdc2 gene. For figures 3-6, the cdc2-asM17 mutant with bsd insertion was used and denoted as cdc2-asM17 for simplicity. The sfi1-CFP SPB marker was removed through backcrossing of the cdc2-asM17-bsd sfi1-CFP-nat strain (MJ1358) with a wild-type strain without markers, to yield MO1893.
Microscopy
Images in figures 1b and 2a were acquired using an Axio Imager.M2 fluorescence microscope and AXIOVISION software (Zeiss, Germany). Live-cell imaging methods for figure 4 were described previously [34] . Briefly, live-cell imaging was performed with the DeltaVision-SoftWoRx system (GE Healthcare, UK). Cultured cells were mounted on a glassbottom dish (Matsunami, Japan) coated with lectin and filled with minimal medium. Serial section images along the z-axis were acquired and stacked using the 'quick projection' protocol in SOFTWORX. Temperature-sensitive strains were observed in a temperature-controlled chamber to maintain 368C during observation. MBC (carbendazim; Sigma, MO) was added to liquid culture at the final concentration of 50 mg ml 21 [76] . 2 mM 1NM-PP1 or DMSO was added to liquid media during observation. Images in figure 5 and electronic supplementary material, figure S3a were acquired by an Axioplan 2 fluorescence microscope (Zeiss) and SLIDEBOOK software (Leeds Precision, UK). Images in figure 6 were taken as described previously [77] .
In vitro kinase assay and Western blotting
Schizosaccharomyces pombe protein extract from wild-type and cdc2-asM17 cells was prepared, and the Cdc2-Cdc13 complex was purified using Suc1-beads (Millipore, MA). The pulldowns containing Cdc2 -Cdc13 were mixed with histone H1 (New England BioLabs, UK) as a substrate, in the absence or presence of 1NM-PP1 (0-10 3 nM). Samples were subjected to SDS -PAGE, and the gel was stained with Coomassie brilliant blue followed by autoradiography. For Western blotting in electronic supplementary material, figure S2 , extracts or pulldowns by Suc1-beads were subjected to SDS-PAGE.
The following antibodies were used: anti-Cdc2 monoclonal (1 : 1000; a gift from Y. Watanabe) and anti-tubulin monoclonal TAT-1 (1 : 5000; a gift from K. Gull).
